
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target
Christina A. Von Roemeling, Laura A. Marlow, Anthony B. Pinkerton, et al.
The Journal of Clinical Endocrinology & Metabolism (2015) Vol. 100, Iss. 5, pp. E697-E709
Open Access | Times Cited: 137
Christina A. Von Roemeling, Laura A. Marlow, Anthony B. Pinkerton, et al.
The Journal of Clinical Endocrinology & Metabolism (2015) Vol. 100, Iss. 5, pp. E697-E709
Open Access | Times Cited: 137
Showing 1-25 of 137 citing articles:
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Lindsay A. Broadfield, Antonino Alejandro Pane, Ali Talebi, et al.
Developmental Cell (2021) Vol. 56, Iss. 10, pp. 1363-1393
Open Access | Times Cited: 417
Lindsay A. Broadfield, Antonino Alejandro Pane, Ali Talebi, et al.
Developmental Cell (2021) Vol. 56, Iss. 10, pp. 1363-1393
Open Access | Times Cited: 417
Lipid metabolism in cancer progression and therapeutic strategies
Yan Fu, Tiantian Zou, Xiaotian Shen, et al.
MedComm (2020) Vol. 2, Iss. 1, pp. 27-59
Open Access | Times Cited: 218
Yan Fu, Tiantian Zou, Xiaotian Shen, et al.
MedComm (2020) Vol. 2, Iss. 1, pp. 27-59
Open Access | Times Cited: 218
Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer
Zuzanna Tracz‐Gaszewska, Paweł Dobrzyń
Cancers (2019) Vol. 11, Iss. 7, pp. 948-948
Open Access | Times Cited: 206
Zuzanna Tracz‐Gaszewska, Paweł Dobrzyń
Cancers (2019) Vol. 11, Iss. 7, pp. 948-948
Open Access | Times Cited: 206
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Shikha Saini, Kiara Tulla, Ajay V. Maker, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 203
Shikha Saini, Kiara Tulla, Ajay V. Maker, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 203
Aberrant lipid metabolism as a therapeutic target in liver cancer
Evans D. Pope, ErinMarie O. Kimbrough, Lalitha Padmanabha Vemireddy, et al.
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 6, pp. 473-483
Open Access | Times Cited: 154
Evans D. Pope, ErinMarie O. Kimbrough, Lalitha Padmanabha Vemireddy, et al.
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 6, pp. 473-483
Open Access | Times Cited: 154
Characterizing dedifferentiation of thyroid cancer by integrated analysis
Han Luo, Xuyang Xia, Gyeong Dae Kim, et al.
Science Advances (2021) Vol. 7, Iss. 31
Open Access | Times Cited: 126
Han Luo, Xuyang Xia, Gyeong Dae Kim, et al.
Science Advances (2021) Vol. 7, Iss. 31
Open Access | Times Cited: 126
CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment
Zongfu Pan, Tong Xu, Lisha Bao, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 70
Zongfu Pan, Tong Xu, Lisha Bao, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 70
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
Alessia Noto, Claudia De Vitis, Maria Elena Pisanu, et al.
Oncogene (2017) Vol. 36, Iss. 32, pp. 4573-4584
Closed Access | Times Cited: 144
Alessia Noto, Claudia De Vitis, Maria Elena Pisanu, et al.
Oncogene (2017) Vol. 36, Iss. 32, pp. 4573-4584
Closed Access | Times Cited: 144
Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism
R. Ariel Igal
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2016) Vol. 1861, Iss. 12, pp. 1865-1880
Closed Access | Times Cited: 139
R. Ariel Igal
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2016) Vol. 1861, Iss. 12, pp. 1865-1880
Closed Access | Times Cited: 139
Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells
Maria Elena Pisanu, Alessia Noto, Claudia De Vitis, et al.
Cancer Letters (2017) Vol. 406, pp. 93-104
Closed Access | Times Cited: 106
Maria Elena Pisanu, Alessia Noto, Claudia De Vitis, et al.
Cancer Letters (2017) Vol. 406, pp. 93-104
Closed Access | Times Cited: 106
SCD1, autophagy and cancer: implications for therapy
Francesca Ascenzi, Claudia De Vitis, Marcello Maugeri‐Saccà, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 92
Francesca Ascenzi, Claudia De Vitis, Marcello Maugeri‐Saccà, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 92
The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model
Pascal Häfliger, Julien Graff, Matthias Rubin, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 86
Pascal Häfliger, Julien Graff, Matthias Rubin, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 86
A new risk factor indicator for papillary thyroid cancer based on immune infiltration
Yang Zhou, Xiyi Wei, Yitong Pan, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 82
Yang Zhou, Xiyi Wei, Yitong Pan, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 82
Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications
Hyunho Yoon, Sanghoon Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2170-2170
Open Access | Times Cited: 63
Hyunho Yoon, Sanghoon Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2170-2170
Open Access | Times Cited: 63
Sorafenib triggers ferroptosis via inhibition of HBXIP/SCD axis in hepatocellular carcinoma
Lu Zhang, Xian-meng Li, Xu-he Shi, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 3, pp. 622-634
Open Access | Times Cited: 49
Lu Zhang, Xian-meng Li, Xu-he Shi, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 3, pp. 622-634
Open Access | Times Cited: 49
Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors
Amogh Gupta, Dipanwita Das, Reshma Taneja
Cancers (2024) Vol. 16, Iss. 7, pp. 1313-1313
Open Access | Times Cited: 15
Amogh Gupta, Dipanwita Das, Reshma Taneja
Cancers (2024) Vol. 16, Iss. 7, pp. 1313-1313
Open Access | Times Cited: 15
METTL16 inhibits papillary thyroid cancer tumorigenicity through m6A/YTHDC2/SCD1-regulated lipid metabolism
Qiang Li, Yaju Wang, Xiangshu Meng, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 13
Qiang Li, Yaju Wang, Xiangshu Meng, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 13
Distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy-sensitive than papillary thyroid cancer
Paul K. J. Han, Weidong Ye, Pengcheng Yu, et al.
JCI Insight (2024)
Open Access | Times Cited: 10
Paul K. J. Han, Weidong Ye, Pengcheng Yu, et al.
JCI Insight (2024)
Open Access | Times Cited: 10
Fatty acid metabolism influences the immune microenvironment in papillary thyroid cancer and identifies SCD as a novel biomarker
Bingbing Shen, Yu Zhang, Yan Tie
Frontiers in Endocrinology (2025) Vol. 16
Open Access | Times Cited: 1
Bingbing Shen, Yu Zhang, Yan Tie
Frontiers in Endocrinology (2025) Vol. 16
Open Access | Times Cited: 1
Evolving molecularly targeted therapies for advanced-stage thyroid cancers
Keith C. Bible, Mabel Ryder
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 7, pp. 403-416
Closed Access | Times Cited: 85
Keith C. Bible, Mabel Ryder
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 7, pp. 403-416
Closed Access | Times Cited: 85
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma
Maria Elena Pisanu, Marcello Maugeri‐Saccà, Luigi Fattore, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 79
Maria Elena Pisanu, Marcello Maugeri‐Saccà, Luigi Fattore, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 79
Sterculic Acid: The Mechanisms of Action beyond Stearoyl-CoA Desaturase Inhibition and Therapeutic Opportunities in Human Diseases
Rafael Peláez, Ana Pariente, Álvaro Pérez-Sala, et al.
Cells (2020) Vol. 9, Iss. 1, pp. 140-140
Open Access | Times Cited: 56
Rafael Peláez, Ana Pariente, Álvaro Pérez-Sala, et al.
Cells (2020) Vol. 9, Iss. 1, pp. 140-140
Open Access | Times Cited: 56
Lipid metabolism in cancer: A systematic review
Dominic Augustine, Wafa Khan, RoopaS Rao, et al.
Journal of Carcinogenesis (2021) Vol. 20, Iss. 1, pp. 4-4
Open Access | Times Cited: 56
Dominic Augustine, Wafa Khan, RoopaS Rao, et al.
Journal of Carcinogenesis (2021) Vol. 20, Iss. 1, pp. 4-4
Open Access | Times Cited: 56
Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases
Md. Shahriare Satu, Md. Imran Khan, Md Rezanur Rahman, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 2, pp. 1415-1429
Open Access | Times Cited: 41
Md. Shahriare Satu, Md. Imran Khan, Md Rezanur Rahman, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 2, pp. 1415-1429
Open Access | Times Cited: 41
Targeting Stearoyl-CoA Desaturase in Solid Tumors
Casie S. Kubota, Peter J. Espenshade
Cancer Research (2022) Vol. 82, Iss. 9, pp. 1682-1688
Open Access | Times Cited: 29
Casie S. Kubota, Peter J. Espenshade
Cancer Research (2022) Vol. 82, Iss. 9, pp. 1682-1688
Open Access | Times Cited: 29